Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, sold 57 shares of common stock on May 17, 2024, to satisfy tax withholding obligations related to vesting restricted stock.

Summary

  • On May 17, 2024, Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc., sold 57 shares of the company's common stock.
  • The sale was executed at a price of $22.18 per share.
  • This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted by Aebersold on February 8, 2021.
  • The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock.
  • Following the transaction, Aebersold directly owns 65,028 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) by an officer, which is neither particularly positive nor negative. The use of a pre-arranged trading plan suggests no unexpected concerns.

Industry Context

Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Key Dates

DateDescription
02/08/2021Date of adoption of Rule 10b5-1(c) trading plan
05/17/2024Date of stock sale transaction
05/21/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.